Yufei Shi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Breast Cancer Cells

Clostridium Difficile

Tyrosine Kinase

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Ligang Liu, Hekai Shi, Yufei Shi, Anlin Wang, Nuojin Guo, Heqing Tao, Milap C Nahata
Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Nuo Xu, Yufei Shi, Yixue Wang, Wen Yao Mak, Wenyu Yang, Kar Weng Ng, Yue Wu, Zhijia Tang, Qingfeng He, Gangfeng Yan, Xiao-Qiang Xiang, Xiao Zhu
Development and Quality Control of a Population Pharmacokinetic Model Library for Caspofungin. Pharmaceutics 16 (6) (2024)
Ligang Liu, Hekai Shi, Yufei Shi, Anlin Wang, Nuojin Guo, Heqing Tao, Milap C Nahata
Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Nuo Xu, Yufei Shi, Yixue Wang, Wen Yao Mak, Wenyu Yang, Kar Weng Ng, Yue Wu, Zhijia Tang, Qingfeng He, Gangfeng Yan, Xiao-Qiang Xiang, Xiao Zhu
Development and Quality Control of a Population Pharmacokinetic Model Library for Caspofungin. Pharmaceutics 16 (6) (2024)
Ligang Liu, Hekai Shi, Yufei Shi, Anlin Wang, Nuojin Guo, Heqing Tao, Milap C Nahata
Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Xiaowen Wang, Fang Chen, Nan Guo, Zhichun Gu, Houwen Lin, Xiaoqiang Xiang, Yufei Shi, Bing Han
Application of physiologically based pharmacokinetics modeling in the research of small-molecule targeted anti-cancer drugs. Cancer chemotherapy and pharmacology (2023)
Xiwei Ji, Xiangrui Meng, Qingfeng He, Xiao-Qiang Xiang, Yufei Shi, Xiao Zhu
Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling. International journal of molecular sciences 24 (1) (2023)
Xiwei Ji, Xiangrui Meng, Qingfeng He, Xiao-Qiang Xiang, Yufei Shi, Xiao Zhu
Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling. International journal of molecular sciences 24 (1) (2023)
Xiwei Ji, Xiangrui Meng, Qingfeng He, Xiao-Qiang Xiang, Yufei Shi, Xiao Zhu
Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling. International journal of molecular sciences 24 (1) (2023)
Wenyu Yang, Wen Yao Mak, Amanda Gwee, Meng Gu, Yue Wu, Yufei Shi, Qingfeng He, Xiao-Qiang Xiang, Bing Han, Xiao Zhu
Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir. Pharmaceutics 15 (7) (2023)